In vivo experiments showed a significant reduction of tumour growth and prolonged survival when PD-L1+/GD2+ NB-bearing mice were treated with ch14.18/CHO combined with anti-PD-1 mAb [4]. This evidence concerns the gene CD274 and neoplasm.